Asembia 2025: A General Landscape of the Pharmaceutical Industry
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
Uncategorized
Pharma company announces it will lay off 83 Boston-area employees
A Cambridge-based pharmaceutical company reported to the state that it is laying off close to a hundred employees.
Pfizer CEO Calls Trump’s Pharma National Security Concerns ‘Legitimate’
Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the pharmaceutical industry tariffs, which Trump has threatened, in part as a way to shore up U.
BioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential
We recently published a list of Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other billionaire Andreas Halvorsen’s stock picks with huge upside potential.
A Presidential Visit to Bsp Pharmaceutical
President of the Republic Sergio Mattarella visited Bsp Pharmaceutical this morning for the traditional appointment on the eve of May 1st, Labor Day. He was welcomed by Aldo Braca, president
AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectors
The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S. levies tariffs on pharma products made in the European Union, provided they are in line with rates for other sectors.
Pharma tariffs would raise drug costs by $51B: Report
A proposed 25% tariff on U.S. pharmacy imports would drive up U.S. drug costs by $51 billion annually, according to an analysis by Ernst & Young reviewed by Reuters. The April 22 analysis, commissioned by the Pharmaceutical Research and Manufacturers of America,
Biotech firm Amgen adding hundreds of jobs, plans $900M New Albany expansion
Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here’s how the company plans to expand.
Pharmaceutical company to cut 83 Boston-area jobs in downsize
An international pharmaceutical research company is preparing to lay off 83 workers in its U.S. headquarters near Boston.
Pharmalittle: We’re reading about tariffs increasing U.S. drug costs, Trump cuts on drug safety, and more
Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting prices as much as 12.9%